Safety of coitally administered tenofovir 1% gel, a vaginal microbicide, in chronic hepatitis B virus carriers: results from the CAPRISA 004 trial. [electronic resource]
Producer: 20140430Description: 405-8 p. digitalISSN:- 1872-9096
- Adenine -- administration & dosage
- Adult
- Anti-Infective Agents, Local -- administration & dosage
- Antiviral Agents -- administration & dosage
- Carrier State -- drug therapy
- Female
- Hepatitis B virus -- drug effects
- Hepatitis B, Chronic -- drug therapy
- Humans
- Organophosphonates -- administration & dosage
- Tenofovir
- Vaginal Creams, Foams, and Jellies -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.